Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 11/20 | 0.54 |
| ▸ | LPL | P06858 | 10/20 | 0.54 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.38 |
| ▸ | KDR | P35968 | 1/20 | 0.38 |
| ▸ | P4HB | P07237 | 1/20 | 0.35 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.34 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.34 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.33 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.33 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.32 |
| ▸ | EGFR | P00533 | 1/20 | 0.32 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.31 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30024835 | 0.93 | LIPG (0.53) | LIPGLPLPDGFRBKDRP4HB | |
| SCHEMBL18180909 | 0.93 | LIPG (0.53) | LIPGLPLPDGFRBKDRP4HB | |
| SCHEMBL31454000 | 0.90 | LIPG (0.50) | LIPGLPLPDGFRBKDRP4HB | |
| SCHEMBL18181002 | 0.90 | LIPG (0.50) | LIPGLPLPDGFRBKDRP4HB | |
| SCHEMBL24654432 | 0.89 | LIPG (0.56) | LIPGLPLPDGFRBKDRP4HB | |
| SCHEMBL30009475 | 0.89 | LIPG (0.56) | LIPGLPLPDGFRBKDRP4HB | |
| SCHEMBL30863683 | 0.89 | LIPG (0.59) | LIPGLPLPDGFRBKDRP4HB | |
| SCHEMBL29918403 | 0.89 | LIPG (0.59) | LIPGLPLPDGFRBKDRP4HB | |
| SCHEMBL18180977 | 0.87 | LIPG (0.61) | LIPGLPLPDGFRBKDRP4HB | |
| SCHEMBL19348890 | 0.87 | LIPG (0.50) | LIPGLPLPDGFRBKDRP4HB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230192665-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230192665-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, ODC1 | LIPG 481/4885LPL 493/4885PDGFRB 2911/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.